Cargando…
Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors
SIMPLE SUMMARY: The lung cancer treatment paradigm has been completely changed by immunotherapy; however, less than half of the treated patients obtain a response, and an even smaller proportion achieve a long survival. Primary and acquired resistance mechanisms and the immune-related adverse events...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777293/ https://www.ncbi.nlm.nih.gov/pubmed/36551630 http://dx.doi.org/10.3390/cancers14246145 |